Stockscreener 앱 받기
0.5099
30.24%
0.1322
Nexalin Technology Inc 주식(NXL)의 최신 뉴스
Nexalin Technology (NXL) Surges 19% as Momentum Builds Toward Key ResistanceFear Greed Extreme - newser.com
House committee directs VA to research brain stimulation for TBI By Investing.com - Investing.com Australia
House committee directs VA to research brain stimulation for TBI - Investing.com
House urges VA to study new deep brain tech for injured veterans - Stock Titan
Nexalin Technology (NXL) Q1 2026 Profit Slips to $-0.11 — Misses Analyst ForecastsExpert Trade Signals - Newser
Nexalin Technology, Inc.Common Stock (NQ: NXL - The Chronicle-Journal
Nexalin Acquires PONM to Expand AI Health Platform - TipRanks
Nexalin Acquires PONM for $1.3 Million in Stock, Adds 24-Month GLV Collaboration - TradingView
Nexalin (NXL) acquires PONM AI health platform in $1.3M stock deal - Stock Titan
Nexalin acquires digital health platform PONM for $1.3M - Investing.com India
Nexalin acquires digital health platform PONM for $1.3M By Investing.com - Investing.com South Africa
Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial - The Manila Times
AI tools for insomnia: Nexalin takes over HALO at-home therapy platform - Stock Titan
Nexalin Technology, Inc. acquired PONM, Inc. from GreenLight Ventures, LLC for $1.3 million. - marketscreener.com
Nexalin Technology (NXL) Trading at $$0.34 — Key Decision Point 2026-05-14Popular Trader Picks - Newser
TradingKey - TradingKey
Number of shareholders of Nexalin Technology, Inc. – NASDAQ:NXL - TradingView
NXL Financials: Income Statement, Balance Sheet & Cash Flow | Nexalin Tech - Stock Titan
Nexalin Technology, Inc. 1Q 2026: Revenue $14.95K, EPS ($0.11) — 10-Q Summary - TradingView
Nexalin Technology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Nexalin Technology (NXL) Q1 loss, cash burn and Nasdaq bid-price warning - Stock Titan
Peer-Reviewed Neuroimaging Data Supports Nexalin’s Technology for Chronic Insomnia - Sleep Review
Nexalin Technology Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView
MSN Money - MSN
How Nexalin Technology (NXL) pricing offsets input costs | Q4 2025: EPS Misses EstimatesStrong Buy - Newser
NXL Stock Price, Quote & Chart | NEXALIN TECHNOLOGY INC (NASDAQ:NXL) - ChartMill
Nexalin reports sleep quality improvement in insomnia study By Investing.com - Investing.com South Africa
Nexalin reports sleep quality improvement in insomnia study - Investing.com
After 4 weeks, Nexalin insomnia study showed no sham-group sleep gain - Stock Titan
Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia - GlobeNewswire
Nexalin Technology appoints Justin Fleet as CFO - MSN
Nexalin Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Quantisnow
Nexalin Technology appoints Justin Van Fleet as CFO - MSN
Nexalin Technology slides after pricing $5M stock offering - MSN
Nexalin announces pivotal insomnia trial, targets Q2 enrollment By Investing.com - Investing.com India
NXL Nexalin Technology Q4 2025 earnings narrowly miss consensus estimates, shares tick higher as investors overlook minor shortfall.Expert Entry Points - Xã Thanh Hà
Nexalin Advances Pivotal Insomnia Trial for HALO Clarity - The Globe and Mail
NXL (Nexalin Technology Inc.) reports narrow Q4 2025 EPS miss, shares rise 18 percent on positive investor sentiment.Binary Event - Cổng thông tin điện tử tỉnh Tây Ninh
Nexalin (NXL) funds 160-patient pivotal HALO Clarity insomnia trial - Stock Titan
Nexalin announces pivotal insomnia trial, targets Q2 enrollment - Investing.com
Nexalin Technology, Inc. to Advance Pivotal Clinical Trial for HALO™ Clarity Device Aimed at Treating Moderate-to-Severe Insomnia - Quiver Quantitative
Nexalin lines up 160-patient insomnia study to support FDA filing - Stock Titan
Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment - The Manila Times
Nexalin Technology : Investor Presentation March 2026 - marketscreener.com
Nexalin Technology (NXL) Stock: Why Growth Investors Chase It (-2.65%) 2026-04-20Hedge Fund Inspired Picks - Cổng thông tin điện tử tỉnh Lào Cai
0.32%
0.17%
자본화:
|
볼륨(24시간):